The gift will establish the Riney Family Multiple Myeloma Research Program Fund, a two-year initiative aimed at accelerating research on multiple myeloma, a type of blood cancer caused by malignant plasma cells that accumulate in the bone marrow. To be led by Dr. Sagar Lonia, the initiative will engage faculty from areas such as cancer immunology, cell and molecular biology, cancer prevention and control, and discovery and developmental therapeutics and will focus on the underlying biology of the disease, the development of new treatments, and clinical research aimed at understanding response rates and drug resistance, among other areas.
The founder of Scottrade Financial Service, Rodger Riney was diagnosed with multiple myeloma in 2015. In addition to the gift to Winship, the Rineys have supported multiple myeloma research at the Washington University School of Medicine and Dana-Farber Cancer Institute.
"Paula and I believe the best opportunity to cure multiple myeloma is to fund important research and researchers at multiple institutions, like [Dr. Lonial] at Winship," said Rodger Riney. "In addition, we have a commitment to generate cross-institutional research with the expectation that the collaborations will accelerate our collective goal of improving outcomes for patients with multiple myeloma."
(Photo credit: Paula and Rodger Riney Foundation)